Suppr超能文献

[骨折的绝对风险与世界卫生组织指南。继发性骨质疏松症患者的治疗]

[Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].

作者信息

Yamauchi Mika

机构信息

Shimane University Faculty of Medicine, Internal medicine 1.

出版信息

Clin Calcium. 2007 Jul;17(7):1106-13.

Abstract

There has been accumulating evidence that various diseases and drugs cause increased risk of fracture. Although the treatment of primary diseases and discontinuation of drugs are the first and ideal option for the cure of secondary osteoporosis, medical intervention for osteoporosis is often necessary. The mechanisms, which induce bone fragility, are supposed to be different, depending on diseases and drugs. Guidelines for the evaluation and treatment of secondary osteoporosis have not been established except glucocorticoid-induced osteoporosis. In patients with osteoporosis caused by primary hyperparathyroidism, hyperthyroidism, diabetes mellitus as well as hormone deprivation therapy, bisphosphonate is effective in increasing bone mineral density but no data have been available about the fracture risk. Guidelines on the management and treatment of each secondary osteoporosis are desirable.

摘要

越来越多的证据表明,各种疾病和药物会增加骨折风险。虽然治疗原发性疾病和停用药物是治愈继发性骨质疏松症的首要和理想选择,但对骨质疏松症进行医学干预往往是必要的。导致骨脆性增加的机制可能因疾病和药物而异。除糖皮质激素诱导的骨质疏松症外,继发性骨质疏松症的评估和治疗指南尚未确立。在原发性甲状旁腺功能亢进、甲状腺功能亢进、糖尿病以及激素剥夺疗法所致骨质疏松症患者中,双膦酸盐可有效提高骨密度,但尚无关于骨折风险的数据。制定每种继发性骨质疏松症的管理和治疗指南很有必要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验